Table 4b.

Results from the subset (N  =  2399) of the retrospective cohort of COVID-19 patients at montefiore health center at bronx under competing risk model, mixture cure model and promotion time cure model with covariates in model plus gender, BMI and charlson index. (Model 2).

	Competing Risk Model		Mixture Cure model					Promotion Time Cure Model
			Uncure Probability		In hospital death for uncured		Prop obs cure
	$\begin{array}{rl}& H{R}_{sub}\\ & (95\text{\%}\mathrm{CI})\end{array}$	p-value	$\begin{array}{rl}& \mathrm{OR}\\ & (95\text{\%}\mathrm{CI})\end{array}$	p-value	$\begin{array}{rl}& HR\\ & (95\text{\%}\mathrm{CI})\end{array}$	p-value	Estimate (95% CI)	$\begin{array}{rl}& H{R}_{imp}\\ & (95\text{\%}\mathrm{CI})\end{array}$	p-value
Statin Use	0.631 (0.489,0.814)	<0.001	0.750 (0.561,1.003)	0.053	0.675 (0.516,0.882)	0.004	0.978 (0.954,1.000)	0.631 (0.488,0.816)	<0.001
Age > 70 vs ≤70	2.242 (1.813,2.773)	<0.001	2.409 (1.853,3.130)	<0.001	1.697 (1.318,2.185)	<0.001		2.239 (1.824,2.749)	<0.001
Statin &Age Group Interaction	0.607 (0.439,0.839)	0.003	0.543 (0.362,0.815)	0.003	0.745 (0.526,1.054)	0.096		0.607 (0.438,0.841)	0.003
Male vs Female	1.396 (1.191,1.636)	<0.001	1.572 (1.287,1.921)	<0.001	1.007 (0.832,1.220)	0.940		1.400 (1.199,1.632)	<0.001
BMI	1.012 (1.001,1.024)	0.036	1.007 (0.993,1.021)	0.311	1.006 (0.993,1.019)	0.350		1.012 (1.001,1.023)	0.027
Charlson Score	1.089 (1.067,1.111)	<0.001	1.096 (1.066,1.127)	<0.001	1.060 (1.034,1.087)	<0.001		1.089 (1.069,1.110)	<0.001